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ABSTRACT
Objective: To investigate the performance of parent-
reported data in identifying physician-confirmed
asthma.
Design and setting: Validation study using linkage
between the Avon Longitudinal Study of Parents and
Children (ALSPAC) and electronic patient records held
within the General Practice Research Database
(GPRD).
Participants: Participants were those eligible to
participate in ALSPAC who also had a record in the
GPRD; this included 765 individuals, just under 4% of
ALSPAC-eligible participants. The analysis was based
on 141 participants with complete parent-reported
asthma data.
Primary and secondary outcome measures: The
main GPRD outcome measure was whether a child
had a diagnosis of asthma before they were nine.
Parent-reported measures were doctor diagnosis of
asthma (before mean age 7.5 years), various
outcomes based on wheezing and breathlessness
recorded longitudinally between 6 months and
8.5 years. Secondary outcomes were bronchial hyper-
responsiveness (BHR), forced expiratory volume in
1 s/forced vital capacity ratio and skin prick test
responses.
Results: Among the 141 participants with complete
parent-reported data, 26 (18%) had an asthma
diagnosis before age nine. Using general practitioner
(GP)-recorded asthma as the gold standard, the
question ‘Has a doctor ever diagnosed your child with
asthma?’ was both sensitive (88.5%) and specific
(95.7%). ‘Ever wheezed’ had the highest sensitivity
(100%) but low specificity (60%). More specific
definitions were obtained by restricting to those who
had wheezed on more than one occasion, experienced
frequent wheeze and/or wheezed after the age of 3,
but these measures had low sensitivities. BHR only
identified 50% of those with a GP-recorded diagnosis.
Conclusions: Parental reports of a doctor’s
diagnosis agree well with a GP-recorded diagnosis.
High specificity for asthma can be achieved by using
detailed wheezing questions, although these
definitions are likely to exclude mild cases of asthma.
Our study shows that linkage between observational
studies and electronic patient records has the
potential to enhance epidemiological research.
INTRODUCTION
Asthma is difﬁcult to measure in epidemio-
logical studies because there are no deﬁnitive
diagnostic criteria. The presence of recur-
rent respiratory symptoms, particularly
wheezing and breathlessness, is central to its
diagnosis in children. Bronchial hyper-
responsiveness (BHR) is also a feature of
asthma1 2 but is not consistently present and
can exist in the absence of clinical symptoms.
Other measures of lung function may be
normal during asymptomatic periods and
can also be abnormal in the presence of
other respiratory diseases.1 Thus, owing to
the variable nature of asthma symptoms—
both between and within individuals—its
diagnosis remains a clinical one and clinical
assessment is regarded as the best method
for validating self-reported asthma data.3
However, clinical examination is costly and
questionnaires are often preferred in epi-
demiological studies. Questions on wheezing,
such as those used in the International Study
of Asthma and Allergies in Childhood
(ISAAC),4 have been shown to provide valid
Strengths and limitations of this study
▪ We were able to successfully link data from the
Avon Longitudinal Study of Parents and Children
(ALSPAC) with the General Practice Research
Database (GPRD).
▪ The richness of the ALSPAC data allowed us to
explore a number of different epidemiological
constructs of asthma definition in relation to a
recorded physician diagnosis.
▪ We were able to compare the relative perform-
ance of objective measurements and lung func-
tion to that of parent-reported symptom data in
identifying physician-confirmed asthma.
▪ Information on wheezing was collected longitu-
dinally between ages 6 months and 8.5 years.
▪ The proportion of participants with complete
self-reported data from ALSPAC was relatively
small.
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measures of the prevalence of asthma in children.5–8
Having said this, it is not possible to reliably distinguish
between wheezing due to viral respiratory infections,
which are common among young children, and wheez-
ing due to asthma. In addition, mistaking other respira-
tory noises as wheezing can lead to over-reporting.7 9 10
Consequently, it has been suggested that questionnaires
should be supplemented by measurements of airway
responsiveness.11 However, several validation studies
have shown that agreement between such measures and
clinical asthma is poor.3
In the UK, childhood asthma is predominantly diag-
nosed and managed in primary care. Linkage to
primary care records therefore provides a potential
means to validate self-reported data. In this study, we
have compared longitudinal data on wheezing and
other respiratory outcomes with linked electronic
patient records to investigate the performance of epi-
demiological data in identifying physician-conﬁrmed
asthma.
METHODS
Subjects
Participants were those eligible to participate in the
Avon Longitudinal Study of Parents and Children
(ALSPAC) who also had a record in the General
Practice Research Database (GPRD; now the Clinical
Practice Research Datalink: http://www.cprd.com). The
GPRD is an anonymised database of primary care
records of around ﬁve million patients in the UK.
ALSPAC has been described in detail previously.12
Brieﬂy, just over 20 000 pregnant women living in and
around Bristol, UK with due dates during 1991–1992
were eligible to take part; 15 247 pregnancies were
recruited (15 390 fetuses, of which 14 701 were alive at
1 year) and these have been followed up since birth (the
ALSPAC website has a searchable data dictionary;
http://www.bris.ac.uk/alspac/researchers/data-access/
data-dictionary/ describing all available data).
Linkage between ALSPAC and the GPRD
Linkage between ALSPAC and the GPRD was conducted
by the National Health Service Information Centre
(NHS IC) as a trusted third party, using a methodology
to preserve anonymity. They had previously linked
ALSPAC participants to the NHS Central Register, with a
99% match rate12; this was carried out on the basis of
NHS ID number, name, date of birth and postcode
using deterministic linkage. With approval from the
NHS National Information Governance Board (NIGB)
Ethics and Conﬁdentiality Committee, the NHS IC used
this information to identify ALSPAC eligible individuals
who also appeared in the GPRD; they then sent an
anonymised linking dataset to be stored securely at the
GPRD. ALSPAC and GPRD data for linked individuals
were merged and analysed in a safe setting at the GPRD
ofﬁces. As GPRD is anonymous and collected on an
opt-out basis, and anonymity was preserved using the
safeguards described above, this piece of research does
not require consent above and beyond the consent
obtained for participation in ALSPAC. However, ALSPAC
has recently been collecting consent from participants,
who are now adults, for ongoing participation in the
study as well as consent to extract information from
health and other administrative records, and any partici-
pants who withdrew from the study or did not agree to
their health records being extracted were excluded from
the linkage.
ALSPAC data
When the children were, on average, 7.5 years old,
mothers were asked (via a postal questionnaire) whether
a doctor had ever diagnosed their child with asthma.
Data on asthma symptoms (wheezing and breathless-
ness) were collected at 6 months and approximately
every 12 months thereafter (at 18, 30, 42, 57, 69, 81, 91
and 103 months). As well as asking whether the child
had wheezed, the mothers were asked whether their
child had experienced ‘wheezing with whistling on the
chest when (s)he breathed’ and, if so, on how many
occasions. Symptom questions referred to the previous
12 months, apart from at 6 and 57 months, which
referred to the past 6 and 15 months, respectively.
A child was deﬁned to have wheezed if the response to
either question about wheezing was yes and not
wheezed if the response to both was no. Frequent
wheeze was deﬁned as wheezing with whistling on the
chest on at least three occasions during the past
12 months. During a clinic attended between 8 and
9 years, forced expiratory volume in 1 s (FEV1) and
forced vital capacity (FVC) were measured by spirometry
and bronchial responsiveness was measured using the
rapid methacholine inhalation test13; the dose–response
slope of FEV1 per µmol methacholine was used to clas-
sify participants into four categories: none, low, moder-
ate and high, based on tertiles of the dose–response
slope; BHR was deﬁned as being the highest tertile.
Sensitisation to house dust mite, cat and mixed grass was
assessed by skin prick tests with a positive response
deﬁned as a mean weal diameter of 2 mm or greater;
this deﬁnition identiﬁed over 90% of participants sensi-
tised to any one of a panel of up to 12 allergens.14
Symptom data were converted to ‘ever wheezed’, ‘ever
reported frequent wheeze’ and ‘ever had breathless-
ness’—all deﬁned as positive if there was a positive
response at any time point and negative if all responses
were negative. Participants were classiﬁed according to
whether or not their FEV1/FVC ratio was less than 85%
and whether or not they had at least one positive skin
prick test.
GPRD data
Patients were deﬁned as having a general practitioner
(GP) diagnosis of asthma if they had a Read code (the
clinical coding system used by GPs in the UK—http://
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www.connectingforhealth.nhs.uk/systemsandservices/
data/uktc/readcodes/index_html) indicating an asthma
diagnosis (any Read code starting with ‘H33’) in their
record. In order to coincide with the timing of ALSPAC
measurements, participants were classiﬁed according to
whether they had a diagnosis before 9 years of age.
Thus, participants who had no asthma diagnosis but left
a GPRD practice before nine were excluded as it could
not be determined whether they were subsequently diag-
nosed with asthma. Conversely, those who were not in
the GPRD from birth were not excluded because his-
toric diagnoses appeared in patients’ records.
Statistical methods
Sensitivity, speciﬁcity and predictive values for ALSPAC
outcomes and combinations of outcomes were calcu-
lated using GP-recorded diagnosis as the gold standard.
Exact CIs were calculated based on binomial probabil-
ities. These analyses were restricted to those with com-
plete parent-reported data from ALSPAC. Because the
question about a doctor’s diagnosis of asthma was asked,
on average, a year earlier than the last wheezing ques-
tion as well as before lung function was measured, this
outcome was also compared to GP-recorded asthma
before age 8 years in order to evaluate the likely impact
of this age gap on the estimated sensitivity and speciﬁ-
city. In order to try to restrict to current asthma, we
looked at whether children with an early diagnosis had
evidence of persistent asthma by school age or beyond.
There was only one child in the complete-case analysis
with an early diagnosis (aged 3) but no further evidence
of asthma. However, since this child left the GPRD at
age 6, it could not be determined whether or not they
had persistent asthma and they were left in the analysis.
Analyses were carried out using Stata V.12.0.
RESULTS
Of the live births linked by the NHS IC, 765 appeared in
the GPRD (this constitutes 4% of those eligible to take
part in ALSPAC); 4 individuals did not want their health
records accessed and 1 registered into and left the
GPRD on the same day. Of the remaining 760 indivi-
duals, 61 without an asthma diagnosis transferred out of
the GPRD before the age of 9, leaving 699 participants
with known asthma status. Of these, 488 (70%) had
enrolled in ALSPAC, 251 (51%) had information on
whether a doctor had ever diagnosed asthma, 141
(29%) had complete parent-reported asthma data;
slightly fewer had BHR, FEV1, FVC and skin prick test
data. Characteristics of all linked individuals with known
asthma status and those included in the analysis are
shown in table 1. Among the former, there were 115
children with a diagnosis of asthma before age 9, giving
a cumulative incidence of 16%. This ﬁgure was slightly
higher (18%) among those with complete ALSPAC data;
these children were also less likely to live in deprived
areas, as indicated by the index of multiple deprivation
(IMD 2007; χ2=18.8, p=0.001).
Table 2 shows the proportions with and without a GP
diagnosis correctly identiﬁed by different ALSPAC vari-
ables, as well as the overall percentage reporting each
outcome. Wheezing was common: 51% of the children
had ever wheezed and 27% reported frequent wheeze
on at least one occasion.
Of the ALSPAC variables, ‘ever wheezed’ had the
highest sensitivity (100%; 95% CI 86.8% to 100%) but low
speciﬁcity (60%; 50.4% to 69.0%). The question ‘Has a
doctor ever diagnosed your child with asthma?’ was both
sensitive (88.5%; 69.8% to 97.6%) and speciﬁc (95.7%;
90.1% to 98.6%). By restricting to those who had wheezed
on more than one occasion, experienced frequent wheeze
or wheezed after the age of 3, more speciﬁc asthma deﬁni-
tions were obtained (table 2 and see online supplementary
table S1). However, the consequent losses in sensitivity
were substantial. Positive and negative predictive values are
given in table 3. These conﬁrm the above results. BHR
only identiﬁed 50% of those with a GP diagnosis; the speci-
ﬁcity was also relatively low (75%). The sensitivities of
FEV1/FVC ratio and skin prick tests were also low (see
online supplementary table S2).
Combining symptoms with reports of a doctor’s diagno-
sis of asthma gave slightly higher speciﬁcities than the
latter alone (table 4), but the sensitivity of each
Table 1 Characteristics of all linked participants with known asthma status compared to those with complete ALSPAC
parent-reported data
GPRD-recorded characteristics
Linked participants who did not
exit GPRD before age 9 (n=699)
Participants with complete ALSPAC
parent-reported data* (n=141)
Sex—male 348 (50%) 70 (50%)
IMD2 quintile—least deprived 68 (13%) 24 (24%)
Second 155 (30%) 30 (30%)
Third 120 (24%) 27 (27%)
Fourth 58 (11%) 8 (8%)
Most deprived 109 (21%) 11 (11%)
Asthma—cumulative incidence 115 (16%) 26 (18%)
*The denominator for IMD is slightly lower (510 for all linked participants with GPRD asthma status at age 9; 100 for those with complete
ALSPAC parent-reported data) as this variable is not complete within GPRD.
ALSPAC, Avon Longitudinal Study of Parents and Children; GPRD, General Practice Research Database; IMD, index of multiple deprivation.
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combination was somewhat lower. The combination with
the highest Youden’s index (sensitivity+speciﬁcity−100%)
was wheezing reported on at least two occasions plus
reports of a doctor’s diagnosis (Youden’s index 74.3%,
compared with a ﬁgure of 84.2% for doctor’s diagnosis
alone). This combination also gave high predictive values,
as did combining frequent wheeze with a doctor’s
diagnosis.
Changing the age cut-off in GPRD from 9 to 8 years
for the question ‘Has a doctor ever diagnosed your child
with asthma?’ had only a small impact on the results: the
sensitivity of this measure increased to 91.3% and the
speciﬁcity decreased to 94.1%.
DISCUSSION
We have found that parental reports of a doctor’s diag-
nosis accurately predicted the cumulative incidence of
asthma in children with complete data recorded on
asthma symptoms from birth to (8.5) years. Deﬁnitions
consisting of wheeze or frequent wheeze reported on
several occasions were more speciﬁc but had low sensitiv-
ity. This is unsurprising, as these criteria would favour
more severe cases. Conversely, the sensitivity of ever
wheezing and wheezing reported on two or more occa-
sions was high but both had comparatively low
speciﬁcities.
An issue in asthma validation studies is that there is no
true gold standard. However, clinical assessment is
regarded as the optimal standard.3 In this study, we have
used linkage to the GPRD to identify ALSPAC partici-
pants with an asthma diagnosis in their GP record.
Although diagnoses in the GPRD have been shown to
be well recorded, particularly for chronic conditions,15
there are some weaknesses with this approach. Low
population coverage of the GPRD meant that only a
small proportion of ALSPAC participants were captured
through this linkage. Further, linked individuals only
had a complete record while registered with a practice
contributing to the GPRD. Having said this, of 165 parti-
cipants in this study who ever had an asthma diagnosis,
65 (39%) were dated before their GPRD registration
date. Also, high agreement between parent reports and
GP records suggest that missing historic diagnoses were
not a substantial issue. A further shortcoming is the
extent of missing ALSPAC data: complete data were only
available for 29% of the linked participants with known
asthma status. If those without complete data were less
likely to complete the questionnaires accurately than
those with complete data, then the levels of agreement
Table 2 Cross tabulation of key ALSPAC asthma
variables and GPRD asthma
ALSPAC
asthma
outcome
GP-recorded diagnosis
of asthma
OverallNo Yes
Doctor diagnosis of asthma by 7.5 years
No 110 (95.7%) 3 113
Yes 5 23 (88.5%) 28 (19.9%)
Ever reported breathlessness in the past 12 months
No 96 (83.5%) 6 102
Yes 19 20 (76.9%) 39 (27.7%)
Ever reported wheezing in the past 12 months
No 69 (60.0%) 0 69
Yes 46 26 (100%) 72 (51.1%)
Wheezing reported on at least two occasions
No 88 (76.5%) 3 91
Yes 27 23 (88.5%) 50 (35.5%)
Wheezing reported after the age of 3 years
No 96 (83.5%) 9 105
Yes 19 17 (65.4%) 36 (25.5%)
Ever reported a frequent wheeze
No 96 (83.5%) 7 103
Yes 19 19 (73.1%) 38 (27.0%)
Reported a frequent wheeze after the age of 3 years
No 110 (95.7%) 11 121
Yes 5 15 (57.7%) 20 (14.2%)
ALSPAC, Avon Longitudinal Study of Parents and Children; GP,
general practitioner; GPRD, General Practice Research Database.
Table 3 PPV and NPV of different asthma outcome measures
ALSPAC asthma outcome PPV (95% CI) NPV (95% CI)
Single outcomes
Doctor diagnosis of asthma 82.1% (63.1% to 93.9%) 97.3% (92.4% to 99.4%)
Ever reported breathlessness 51.3% (34.8% to 67.6%) 94.1% (87.6% to 97.8%)
Ever reported wheezing 36.1% (25.1% to 48.3%) 100% (94.8% to 100%)
Wheezing reported on two or more occasions 46.0% (31.8% to 60.7%) 96.7% (90.7% to 99.3%)
Reported wheezing after age 3 47.2% (30.4% to 64.5%) 91.4% (84.4% to 96.0%)
Ever reported a frequent wheeze 50.0% (33.4% to 66.6%) 93.2% (86.5% to 97.2%)
Reported a frequent wheeze after age 3 75.0% (50.9% to 91.3%) 90.9% (84.3% to 95.4%)
Combinations of outcomes
Ever wheezed+ever breathless 55.6% (38.1% to 72.1%) 94.3% (88.0% to 97.9%)
Ever symptoms+doctor diagnosis 90.0% (68.3% to 98.8%) 93.4% (87.4% to 97.1%)
Wheezing on ≥2 occasions+doctor diagnosis 87.0% (89.3% to 98.1%) 94.9% (89.3% to 98.1%)
Ever reported a frequent wheeze+doctor diagnosis 94.4% (72.7% to 99.9%) 92.7% (86.6% to 96.6%)
ALSPAC, Avon Longitudinal Study of Parents and Children; NPV, negative predictive value; PPV, positive predictive value.
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presented here could be overestimates. However, the
relative performance of the measures is unlikely to have
been affected.
The main difference between this study and the
majority of other asthma validation studies is that the
symptom data in the latter were cross-sectional, so
wheezing questions generally referred to the past
12 months and coincided with the timing of clinical
assessment. These studies have generally concluded that
wheezing questions are good at identifying asthmatics.
A few studies have looked at ‘ever wheezing’ to estimate
the cumulative incidence of asthma. In these studies, the
sensitivity and speciﬁcity of ‘ever wheezing’ ranged from
80.6% to 94.5% and 74.9% to 89.9%, respectively.5 16–18
However, in each case, this was based on a question
asked at only one point in time. Jenkins et al7 found that
reported wheezing was better at identifying adults than
children with asthma and suggested that parents
unfamiliar with wheezing may misreport other respira-
tory sounds as wheezing. Asking the question, ‘Has your
child ever wheezed?’ at one time point is more likely to
include children with persistent wheezing or asthma
diagnosis due to difﬁculties of parental recall of sporadic
wheeze in early childhood.19 Because we asked questions
about wheezing throughout early childhood, this may
have included a higher proportion of participants who
had viral infections causing wheezing. It has been esti-
mated that 30–50% of preschool children experience
episodic viral wheeze at least once.20 This is supported
by a Swedish study, where the prevalence of wheezing
ranged from 26.6% among those aged 1–2 to 13.2%
among those aged 5–6, whereas the prevalence of
doctor-diagnosed asthma at these ages was 3.6% and
5.7%, respectively.17 Further, results from another study
showed that 48.5% of children aged 6 years had
ever wheezed but 41% of these had transient early
wheezing—at least one lower respiratory tract infection
with wheezing before the age of 3 but no wheezing at
6 years; the majority of this group had no increased risk
of asthma in later life.21 Our results regarding reported
doctor-diagnosed asthma generally agree with previously
published results. One study reported a sensitivity of
76.9% and a speciﬁcity of 97.5% for current doctor-
diagnosed asthma, as determined from medical
records.17 Two recent studies of the cumulative inci-
dence of childhood asthma determined from GP
(UK-based) or health claims data (Canada) compared
with parent-reported diagnosis reported high speciﬁci-
ties but relatively low sensitivities.22 23 Finally, de Marco
et al8 found that the question ‘Have you ever had
asthma?’ agreed most closely with clinical diagnosis.
Owing to the lack of ﬁrm diagnostic criteria, the meas-
urement of asthma in epidemiological studies is prob-
lematic. Using ever wheezing measured longitudinally
from early childhood as a proxy for asthma is likely to
greatly overestimate its prevalence, whereas reports of a
doctor’s diagnosis will estimate it reasonably accurately.
Our results suggest that there is no ‘ideal’ way to deﬁne
asthma in terms of wheezing alone. A measure which
correctly identiﬁes the majority of non-asthmatics will
not pick up a very large proportion of children with
asthma, and vice versa. Having said this, the purpose of
an epidemiological study is often to identify risk factors
rather than to estimate prevalence. In general, relative
risks will be biased towards the null in the presence of
non-differential misclassiﬁcation, and this is particularly
dependent on a measure’s speciﬁcity.24 Pekkanen and
Pearce3 suggest that a highly speciﬁc measure could be
achieved by using a combination of BHR and symptoms
or BHR, symptoms and reported doctor diagnosis. In
our study, combining symptoms or BHR with a doctor’s
diagnosis certainly achieved high speciﬁcities. However,
these combinations were not very sensitive and a
doctor’s diagnosis performed almost as well in terms of
speciﬁcity but misclassiﬁed fewer asthmatics. Further,
very high speciﬁcities were achieved by combining
wheezing outcomes with reports of a doctor’s diagnosis,
and these also misclassiﬁed fewer asthmatics. Peat et al
suggest that using reports of a doctor’s diagnosis is not a
good way to detect participants with current severe
asthma. They argue that identifying this group is import-
ant for determining risk factors and that this can be
achieved with BHR.25 Our data do not support this, as
65% of those with BHR had never received a diagnosis
of asthma. Similarly, only 74% of those with BHR had
ever wheezed.
In conclusion, we have found that parental reports of
a doctor’s diagnosis of asthma agree well with clinical
records; we recommend that this question is incorpo-
rated into epidemiological questionnaires to supplement
symptom data. The use of wheezing to deﬁne asthma is
more problematic but our results suggest that reasonably
high speciﬁcity can be achieved by using conditional
questions about wheezing, although at the cost of lower
sensitivity and failure to identify (probably) milder
cases. We have also shown that linking data from
Table 4 Combination of outcomes versus GPRD asthma
ALSPAC asthma outcome
GP-recorded diagnosis
of asthma
No Yes
Ever reported wheezing+ever reported breathlessness
No 99 (86.1%) 6
Yes 16 20 (76.9%)
Ever reported symptoms+doctor diagnosis by 7.5 years
No 113 (98.3%) 8
Yes 2 18 (69.2%)
Wheezing reported on ≥2 occasions+doctor diagnosis
No 112 (97.4%) 6
Yes 3 20 (76.9%)
Ever reported a frequent wheeze+doctor diagnosis
No 114 (99.1%) 9
Yes 1 17 (65.4%)
ALSPAC, Avon Longitudinal Study of Parents and Children; GP,
general practitioner; GPRD, General Practice Research Database.
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observational studies to electronic patient records can
be an effective means of validating parent-reported data,
as well as providing a source of outcome data that may
otherwise be missing. However, it should be acknowl-
edged that the success of this methodology relies on
good coverage of relevant datasets as well as low levels of
dissent from participants to link to these.
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